-
FDA sets May 2027 decision date on AMT-130 gene therapy for HD
4 min read
Latest News
-
October 2026: This Month in Huntington’s Disease Research
4 min read
From sticky thoughts and pigs that model HD to DNA repair and promising drug trial results, October brought fresh insights into HD. Here’s what you might have missed!
-
Liver changes in Huntington's disease patients suggest more 'whole body' research needed
6 min read
A new study suggests that liver changes may occur in HD patients, opening up new avenues of research
-
The 'N17' region of huntingtin protein: an address label in Huntington's disease?
7 min read
New research sheds light on where the huntingtin protein ends up inside our cells, and why
-
HDBuzz Special Feature: Huntington's disease and sleep
8 min read
Why do many Huntington's disease patients have trouble sleeping, and what can be done about it?
-
The University of New Orleans has NOT discovered a cure for Huntington's disease
7 min read
The science behind an extraordinary press release claiming to have discovered 'A Way to Delay Symptoms of HD'
-
Gone fishing: protein network screen identifies new therapeutic targets in Huntington's disease
9 min read
'Discovery-driven' screen reveals new protein networks involved in Huntington's disease damage & new drug targets
-
Prana Biotech publishes Huntington's disease animal model data for PBT2
6 min read
Prana Biotechnology has released data demonstrating their drug, PBT2, is effective in animal models of HD
-
'Guard dog' proteins reveal surprising connections between Huntington's disease and other brain disorders
7 min read
DNA/RNA-binding proteins may be involved in the damage caused by Huntington's disease and other major brain disorders
-
Dyeing to prevent dying? Methylene blue beneficial in Huntington's disease mice
7 min read
A bolt from the blue – methylene blue may fight Huntington's disease by preventing protein clumps
-
Prominent Huntington's disease researcher "fabricated data" in grant applications
2 min read
Noted Huntington's disease researcher found to have falsified data on grant applications – but published findings sta
-
Calming down the immune system helps Huntington's disease mice
10 min read
CB2-activating drug improves survival and symptoms in Huntington's disease mice through calming down the immune syste
HDBuzz Trial Tracker
FDA accepts BLA for Priority Review, with a target decision date of 1 May 2027.
Show 8 more Show less
Updates from the ongoing Phase 3 INVEST-HD trial of votoplam
Updates from the Phase 1b/2a REGEN4HD trial of neural stem cell therapy hNSC-01
Updates from the ongoing Phase 2/3 FALCON-HD trial of SKY-0515
